News Releases |
ACOG Urges Supreme Court to Protect Mifepristone Access
Washington, D.C.–The following is a statement from the American College of Obstetricians and Gynecologists (ACOG):
“Mifepristone is a safe, effective, and necessary medication that has been used by millions of patients over the course of more than two decades and should remain available nationwide without medically unnecessary and burdensome restrictions. We are hopeful that after hearing this case, the Supreme Court will recognize the overwhelming evidence supporting the safety and critical importance of mifepristone for reproductive health indications and reject this unfounded, unscientific, and politically motivated attack on essential health care.
“Mifepristone litigation has only created more confusion around the availability of mifepristone in an era in which timely access to reproductive health care is critically important. Our members and the patients they treat deserve to know that evidence-based standard-of-care treatments will be available to them without delays or unnecessary restrictions. ACOG strongly opposes burdensome restrictions on mifepristone, including those the FDA has removed with good reason, such as arbitrary gestational age limits and in-person dispensing requirements that do nothing to improve mifepristone’s effectiveness or safety and instead only diminish access. Ideology and bias have no place in the practice of medicine. The Supreme Court must recognize that scientifically proven medical care must remain available to those who need it, and that the FDA’s evidence-based scientific authority cannot be undermined by activists based on an ideological or political agenda.
“We urge the court to rule in favor of the more than two decades of data proving that mifepristone is a safe, effective, and essential medication that should be available to patients; uphold the FDA’s evidence-based decision to approve mifepristone; and return medical decisions to where they belong: to patients and their doctors.”
Read ACOG’s amicus brief encouraging the Supreme Court to take up the case.